June 2015 Archives

Euro zone finance ministers agreed to meet tomorrow which lifted the markets to a higher close with the Dow rising 23 points to 17,619. Nasdaq gained 28 points to 4,986.

On the upside

RBC Capital Markets initiated coverage of Fitbit (NYSE: FIT) with an Outperform rating.

RCS Capital (NYSE: RCAP) agreed to credit modifications with its secured lenders.
 
Bargain hunters lifted shares of Progenics Pharmaceuticals (Nasdaq: PGNX).

On the downside

Pieris Pharmaceuticals (Nasdaq: PIRS) elected Dr. Jean-Pierre Bizzari to its Board of Directors at the annual shareholders meeting today.

Australia cut its iron ore price forecast for 2015 sending shares of Cliffs Natural Resources (NYSE: CLF) lower.

Willis Group will acquire Towers Watson (Nasdaq: TW) in an all stock deal valued at approximately $18 billion.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 2 on the NYSE and by 5 to 3 on Nasdaq. The broader S&P 500 gained 5 points to 2063. Bitcoin climbed $8 to $263.
The markets traded higher with the Dow adding 30 points to 17,627 as Greece asked for additional funds to avert a bankruptcy. Nasdaq rose 23 points to 4,982.

On the upside

KeyBanc Capital Markets analyst Akshay Jagdale said that TreeHouse Foods (NYSE: THS) could potentially buy ConAgra's (NYSE: CAG) private label foods business.

Bargain hunters lifted shares of Advaxis (Nasdaq: ADXS).
 
Alder BioPharmaceuticals (Nasdaq: ALDR) president and chief executive Randall C. Schatzman will present today at the Washington Biotechnology and Biomedical Association 2015 Life Science Innovation Northwest conference.

On the downside

Shares of Ambac Financial (Nasdaq: AMBC) extended its losses.

Shares of Real Goods Solar (Nasdaq: RGSE) continued falling.

Tuesday Mornings (Nasdaq: TUES) chief financial officer Jeffrey N. Boyer resigned.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on both the NYSE and on Nasdaq. The broader S&P 500 rose 4 points to 2062. Bitcoin climbed $12 to $267.
The markets opened higher with the Dow rising 60 points to 17,656 as Greece engaged in last minute talks with euro zone officials. Nasdaq gained 26 points to 4,984.

On the upside

Signal Genetics (Nasdaq: SGNL) signed a Master Service Agreement with a leading pharmaceutical to conduct multiple clinical trials using Signal's MyPRS(R) genetic test to develop treatments for patients with multiple myeloma.

Juno Therapeutics (Nasdaq: JUNO) entered a 10-year, $1 billion collaboration agreement with Celgene (Nasdaq: CELG).
 
Bargain hunters lifted shares of Melco Crown Entertainment (Nasdaq: MPEL).

On the downside

Apollo Education (Nasdaq: APOL) reported lower third quarter earnings and revenue and cut its full year guidance prompting a downgrade.

Standard & Poor's Ratings Services downgraded the credit rating of Puerto Rico sending shares of MBIA (NYSE: MBI) lower.

Investors locked in profits on Peabody Energy (NYSE: BTU).
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 2 on both the NYSE and on Nasdaq. The broader S&P 500 gained 7 points to 2065. Bitcoin climbed $9 to $264.
The markets plummeted with the Dow collapsing 350 points to 17,596 as Greece edged closer to bankruptcy. Nasdaq sank 122 points to 4,958.

On the upside

Bargain hunters lifted shares of China Digital TV (NYSE: STV).

Shares of coal producer Cloud Peak Energy (NYSE: CLD) rose on the Supreme Court's ruling that the Environmental Protection Agency must consider costs when imposing new air pollution regulation.
 
On the downside

Shares of Real Goods Solar (Nasdaq: RGSE) extended its losses.

Puerto Rico's announcement that it may not be able to make debt payments weighed down share of Puerto Rican financial services provider OFG Bancorp (NYSE: OFG).

Mad Money's Jim Cramer said on Friday that Micron Technology (Nasdaq: MU) would continue falling due to price competition.

TheStreet expects Bank of America (NYSE: BAC) stock to drop.
 
In the broad market, declining issues outpaced advancers by a margin of nearly 10 to 1 on the NYSE and by more than 7 to 1 on Nasdaq. The broader S&P 500 plummeted 43 points to 2057. Bitcoin gained $7 to $254.

Markets plummet on Greek woes

|
The collapse of Greek debt discussions sparked fears that Greece will exit the euro zone. The markets plunged during the midday with the Dow slumping 226 points to 17,719. Nasdaq plummeted 72 points to 5,008.

On the upside

Shares of Peabody Energy (NYSE: BTU) rose after the Supreme Court ruled that costs must be considered when the Environmental Protection Agency implements new air pollution regulations.

Aratana Therapeutics (Nasdaq: PETX) reported positive results from a field effectiveness study of the appetite stimulation drug capromorelin for dogs.
 
On the downside

Shares of DS Healthcare Group (Nasdaq: DSKX) extended its losses.

Guggenheim downgraded First Bancorp (NYSE: FBP) from a Buy rating to a Neutral rating.

Comments by Puerto Rico Governor Alejandro Garcia Padilla that Puerto Rico would not be able to pay its debts sent shares of financial services firm Popular (Nasdaq: BPOP) tumbling.

Shares of Cheetah Mobile (NYSE: CMCM) continued to fall.
 
In the broad market, declining issues outpaced advancers by a margin of nearly 6 to 1 on the NYSE and by more than 4 to 1 on Nasdaq. The broader S&P 500 plunged 26 points to 2074. Bitcoin gained $8 to $255.

Greek default fears sink stocks

|
Fears of a Greek default sent the markets down to a sharply lower open with the Dow plunging 127 points to 17,819. Nasdaq tumbled 41 points to 5,039.

On the upside

Sterne Agee upgraded Chesapeake Energy (NYSE: CHK) from an Underperform rating to a Buy rating and lifted its price target from $9 to $13.

Shares of Petrobras (NYSE: PBR) extended its gains.
 
On the downside

Shares of National Bank of Greece (NYSE: NBG) fell as Greek banks remained closed on Monday and a 60 euros daily limit on ATM cash withdrawals was implemented.

Puerto Rico's announcement that it would be not be able to pay its debts sent shares of bond insurers Assured Guaranty (NYSE: AGO) and MBIA (NYSE: MBI) tumbling.

Profit taking weighed down shares of Seres Therapeutics (Nasdaq: MCRB).

Investors locked in profits on Penn Virginia (NYSE: PVA).
 
In the broad market, declining issues outpaced advancers by a margin of nearly 7 to 2 on both the NYSE and on Nasdaq. The broader S&P 500 dropped 13 points to 2087. Bitcoin rose $6 to $253.
The markets closed mixed with the Dow gaining 56 points to 17,946 as the deadline for Greece to approve a debt deal approached. Nasdaq lost 31 points to 5,080.

On the upside

Shares of AppFolio (Nasdaq: APPF) soared in its market debut.

BioLineRx (Nasdaq: BLRX) stock climbs again.

Shares of Winnebago (NYSE: WGO) extended its gains from yesterday when the recreational vehicle maker reported better than expected third quarter results.
 
On the downside

Real Goods Solar (Nasdaq: RGSE) priced its public offering of common stock and warrants at $3.65 per unit.

Concerns about a Chinese stock market bubble sent shares of Youku Tudou (NYSE: YOKU) tumbling.

Investors locked in profits on Glaukos (NYSE: GKOS).
 
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 4 on the NYSE and by more than 7 to 5 on Nasdaq. The broader S&P 500 edged down a fraction to 2101. Bitcoin eased a fraction to $241. 
The markets traded mixed during the midday with the Dow gaining 81 points to 17,972 as negotiations continued to avert a Greek default. Nasdaq fell 21 points to 5,090.

On the upside

Shares of Alarm.com (Nasdaq: ALRM) surged in its market debut.

Seres Therapeutics (Nasdaq: MCRB) stock leaped on its first trading day.

Shares of Xactly (NYSE: XTLY) soared in its market debut.
 
On the downside

Shares of Peabody Energy (NYSE: BTU) extended its losses.

Profit taking continued to weigh down shares of E-Commerce China Dangdang (NYSE: DANG).

Investors locked in profits on Jumei International Holding (NYSE: JMEI).
 
In the broad market, declining issues outpaced advancers by a margin of nearly 10 to 9 on the NYSE and by nearly 3 to 2 on Nasdaq. The broader S&P 500 added a point to 2103. Bitcoin eased a fraction to $241.
A greater than expected gain in consumer sentiment lifted the markets to a higher open with the Dow climbing 89 points to 17,979. Nasdaq slipped 5 points to 5,107.

On the upside

Shares of Cleveland BioLabs (Nasdaq: CBLI) continued to climb.

National Bank of Greece (NYSE: NBG) stock rose as Greece moved closer to a debt deal.

Bargain hunters lifted shares of Magnum Hunter Resources (NYSE: MHR).
 
On the downside

Celladon (Nasdaq: CLDN) will suspend development of all programs and will aggressively pursue the sale of the company.

Micron (Nasdaq: MU) disappointed with lower third quarter earnings and revenue that missed expectations prompting a downgrade.

The Wall Street Journal reported that Valeant Pharmaceuticals (NYSE: VRX) was exploring a possible acquisition of Zoetis (NYSE: ZTS).
 
In the broad market, declining issues outpaced advancers by a margin of more than 10 to 9 on the NYSE and by nearly 10 to 9 on Nasdaq. The broader S&P 500 added 3 points to 2106. Bitcoin eased a fraction to $241.
The markets closed lower with the Dow falling 75 points to 17,890 despite strong consumer spending as a Greek deal remained elusive. Nasdaq lost 10 points to 5,112.

On the upside

Shares of Community Health Systems (NYSE: CYH) climbed after the Supreme Court ruled that federal subsidies for health insurance can continue.

Proactive Investors reported that BP (NYSE: BP) offered to buy Penn Virginia (NYSE: PVA).

Shares of Lantheus Holdings (Nasdaq: LNTH) rose on its first trading day.
 
On the downside

Investors continued to take profits on TrovaGene (Nasdaq: TROV).

JPMorgan downgraded Williams Companies (NYSE: WMB) from an Overweight rating to a Neutral rating and cut its price target from $65 to $60.

Alder BioPharmaceuticals (Nasdaq: ALDR) will offer $200 million worth of common stock.
 
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by nearly 5 to 4 on Nasdaq. The broader S&P 500 lost 6 points to 2102. Bitcoin edged up $1 to $242.
Stronger than expected May consumer spending lifted the markets during the midday with the Dow rising 34 points to 18,000. Nasdaq gained 14 points to 5,136.

On the upside

Shares of Glaukos (NYSE: GKOS) surged on its first trading day.

The Supreme Court's ruling that government healthcare subsidies can continue lifted shares of HCA (NYSE: HCA) and Tenet Healthcare (NYSE: THC).

Shares of Catabasis Pharmaceuticals (Nasdaq: CATB) rose in its market debut.
 
On the downside

Profit taking weighed down shares of Celator Pharmaceuticals (Nasdaq: CPXX).

Shares of Vale (NYSE: VALE) extended its losses.

Petrobras (NYSE: PBR) will ask a New York judge to dismiss investor lawsuits.
 
In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 4 on the NYSE while advancers edged out decliners by nearly 5 to 4 on Nasdaq. The broader S&P 500 rose 5 points to 2114. Bitcoin added $2 to $242.
The markets opened flat with the Dow adding 3 points to 17,969 as the deadline for a Greek deal loomed. Nasdaq rose 7 points to 5,129.

On the upside

Cleveland BioLabs (Nasdaq: CBLI) entered a purchase agreement with a venture capital investor for approximately $25 million.

Magnum Hunter Resources (NYSE: MHR) will sell its entire equity ownership in Eureka Hunter Holdings.

Real Goods Solar (Nasdaq: RGSE) converted all of its subordinated debt into Class A common stock and will exchange most of its Series A and C warrants for Class A common stock.
 
On the downside

Cree (Nasdaq: CREE) will restructure its LED business and announced a stock repurchase plan.

Fourth quarter earnings fell for Methode Electronics (NYSE: MEI).

FBR Capital downgraded World Acceptance (Nasdaq: WRLD) from an Outperform rating to a Market Perform rating and slashed its price target from $98 to $73.
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 3 to 2 on the NYSE and by nearly 2 to 1 on Nasdaq. The broader S&P 500 edged up to 2109. Bitcoin added $2 to $242.
Doubts that Greece will reach a deal with its creditors sank the markets with the Dow plummeting 178 points to 17,966. Nasdaq dropped 37 points to 5,122.

On the upside

Turtle Beach (Nasdaq: HEAR) partnered with AuDConnex to distribute its HyperSound Clear hearing healthcare solution.

Flotek Industries (NYSE: FTK) chief executive John Chisholm will present at the Global Hunter Securities GHS 100 Energy Conference next Wednesday.

Topeka Capital Markets upgraded Merge Healthcare (Nasdaq: MRGE) from a Hold rating to a Buy rating.
 
On the downside

Investors locked in profits on DS Healthcare Group (Nasdaq: DSKX).

Progenics Pharmaceuticals (Nasdaq: PGNX) chief executive Mark R. Baker will present at the Cantor Fitzgerald's Inaugural Healthcare Conference on July 8, 2015 but the stock price fell.

Shares of Willbros Group (NYSE: WG) continued falling.
 
In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 2 on the NYSE and by more than 5 to 2 on Nasdaq. The broader S&P 500 tumbled 15 points to 2108. Bitcoin slipped $2 to $242.

Markets fall on Greek talks

|
The markets traded lower during the midday with the Dow dropping 58 points to 18,085 on reported setbacks to Greek negotiations. Nasdaq lost 8 points to 5,151.

On the upside

Elite Investments wrote that Synthesis Energy (Nasdaq: SYMX) was poised to soar.

Box (NYSE: BOX) partnered with IBM (NYSE: IBM) to develop innovative solutions to transform work in the cloud.

Nektar Therapeutics (Nasdaq: NKTR) will replace Casey's General Stores (Nasdaq: CASY) in the S&P SmallCap 600 after market close on June 25, 2015.
 
On the downside

Peabody Energy (NYSE: BTU) will be replaced on the S&P MidCap 400 by Cable ONE after market close on June 30, 2015.

Paragon Offshore (NYSE: PGN) will be replaced by Semtech (Nasdaq: SMTC) on the S&P SmallCap 600 after market close on June 30, 2015.

Investors locked in profits on Energous (Nasdaq: WATT).
 
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by nearly 2 to 1 on Nasdaq. The broader S&P 500 lost 4 points to 2119. Bitcoin slipped $4 to $240.
Indications that Greek debt negotiations may be faltering weighed the markets down to a lower open with the Dow falling 56 points to 18,087. Nasdaq slipped 4 points to 5,155.

On the upside

Celator Pharmaceuticals (Nasdaq: CPXX) reported positive induction response rates in a Phase 3 study of CPX-351 liposome injection to treat patients with high-risk acute myeloid leukemia.

MeetMe (Nasdaq: MEET) lifted its earnings and revenue outlook for the second quarter.

Catalyst Pharmaceuticals (Nasdaq: CPRX) reported positive top-line results from a proof-of-concept trial of CPP-109 to treat patients with Tourette's Disorder.
 
On the downside

Transition Therapeutics (Nasdaq: TTHI) reported disappointing results from a Phase2/3 clinical study of ELND005 in treating agitation and aggression in Alzheimer's Disease patients.

Global Equities Research analyst Trip Chowdhry said that Fitbit (NYSE: FIT) stock was hyper-inflated and recommended that investors lock in profits.

Alcobra (Nasdaq: ADHD) reported disappointing results from a Phase 2 clinical trial MDX to treat Fragile X Syndrome.
 
In the broad market, declining issues outpaced advancers by a margin of 10 to 9 on the NYSE and by nearly 7 to 5 on Nasdaq. The broader S&P 500 slipped 3 points to 2120. Bitcoin slipped $2 to $242.
The markets closed modestly higher with the Dow rising 24 points to 18,144 as investors continued to monitor Greek negotiations. Nasdaq added 6 points to 5,160.

On the upside

Shares of Novavax (Nasdaq: NVAX) extended its gains as investors anticipate the release of data from four ongoing clinical trials in the third quarter.

Standard & Poor's upgraded Halcon Resources' (NYSE: HK) corporate credit rating from SD (selective default) to B-.

Bill Barrett (NYSE: BBG) chief executive Scot Woodall presented at the Global Hunter Securities 100 Energy Conference today.
 
On the downside

NN (Nasdaq: NNBR) announced a pubic offering of 6 million common shares.

NRG Yield (NYSE: NYLD) will offer $250 million in convertible senior notes.

New Senior Investment Group (NYSE: SNR) will offer 17.5 million common shares.
 
In the broad market, advancing issues outpaced decliners by a margin of 7 to 5 on the NYSE and by 9 to 7 on Nasdaq. The broader S&P 500 added a point to 2124. Bitcoin slipped $2 to $245.
The markets traded flat during the midday with the Dow adding 13 points to 18,133 as durable goods orders dropped last month. Nasdaq slipped 2 points to 5,151.

On the upside

Momo (Nasdaq: MOMO) co-founder and chief executive Yan Tang along with three investment firms offered to take Momo private for a premium of $18.90 per American Depositary Share.

Bargain hunters lifted shares of Magnum Hunter Resources (NYSE: MHR).

Key Energy Services (NYSE: KEG) named Robert Drummond to the position of president and chief operating officer.
 
On the downside

CorEnergy Infrastructure Trust (NYSE: CORR) will offer 11.25 million common shares through a public offering and $75 million of unsecured convertible senior notes.

Synergy Pharmaceuticals (Nasdaq: SGYP) initiated the second Phase 3 clinical trial of plecanatide to treat irritable bowel syndrome with constipation.

BlackBerry (Nasdaq: BBRY) reported a wider than expected loss for the first quarter as revenue fell.
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 10 to 9 on the NYSE while decliners edged out advancers by nearly 5 to 4 on Nasdaq. The broader S&P 500 held steady at 2122. Bitcoin slipped $3 to $244.
The markets opened mixed with the Dow rising 33 points to 18,152 while Nasdaq slipped 5 points to 5,148 as durable goods orders fell in May.

On the upside

PhotoMedex (Nasdaq: PHMD) sold its XTRAC and VTRAC psoriasis and vitiligo treatment businesses to MELA Sciences (Nasdaq: MELA) for $42.5 million in cash.

Bargain hunters snapped up shares of Ambarella (Nasdaq: AMBA).

Green Dot (NYSE: GDOT) extended its contract with Walmart (NYSE: WMT) to continue serving as the program manager and issuing bank for the Walmart MoneyCard suite of prepaid reload able debit card products.
 
On the downside

Vical (Nasdaq: VICL) reported disappointing results from an ongoing Phase 1/2 clinical study of its genital herpes vaccine.

Sonic (Nasdaq: SONC) reported higher third quarter earnings and revenue but the restaurant chain warned that the macroeconomic environment may negatively impact full year results.

GasLog Partners (NYSE: GLOP) priced its public offering of 7.5 million common units at the discounted price of $23.90 per unit.
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 4 on the NYSE and by nearly 3 to 2 on Nasdaq. The broader S&P 500 rose 3 points to 2126. Bitcoin slipped $3 to $244.
Indications that Greece moved closer to a debt deal boosted the markets to a sharply higher close with the Dow soaring 103 points to 18,119. Nasdaq climbed 36 points to 5,153.

On the upside

Goodrich Petroleum (NYSE: GDP) began completion operations on two of six uncompleted wells in the Tuscaloosa Marine Shale.

Hach will acquire Sutron (Nasdaq: STRN) in an all cash deal valued at approximately $39 million.

China Information Technology (Nasdaq: CNIT) received an offer to take the company private.
 
On the downside

AK Steel (NYSE: AKS) blamed lower carbon steel prices for widening its loss forecast for the second quarter.

DS Healthcare Group (Nasdaq: DSKX) announced a distribution agreement in Egypt with MultiTrade but the stock price fell.

Shares of Williams Partners (NYSE: WPZ) dropped even as Williams Companies (NYSE: WMB) rejected an acquisition offer from Energy Transfer Equity (NYSE: ETE).
 
In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 2 on the NYSE and by more than 5 to 3 on Nasdaq. The broader S&P 500 gained 12 points to 2122. Bitcoin rose $4 to $247.

Greece near deal, markets soar

|
Optimism that Greece and its creditors were close to finalizing a deal sent the markets soaring during the midday with the Dow climbing 105 points to 18,121. Nasdaq gained 32 points to 5,149.

On the upside

Epizyme (Nasdaq: EPZM) reported positive results from an ongoing Phase 1 study of tazemetostat to treat patients with advanced B-cell non-Hodgkin lymphomas and solid tumors.

JMP Securities initiated coverage of Akebia Therapeutics (Nasdaq: AKBA) with a Market Outperform rating.

Transgenomic (Nasdaq: TBIO) will launch up to six new genetic cancer tests this year.
 
On the downside

William Blair downgraded Polycom (Nasdaq: PLCM) from a Market Perform rating to an Underperform rating.

Profit taking continued to weigh down shares of Synergy Pharmaceuticals (Nasdaq: SGYP).

Shares of FuelCell Energy (Nasdaq: FCEL) extended its losses.
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 3 on the NYSE and by more than 5 to 3 on Nasdaq. The broader S&P 500 gained 12 points to 2122. Bitcoin rose $3 to $246.
A possible Greek deal lifted the markets to a sharply higher open with the Dow soaring 133 points to 18,149. Nasdaq climbed 41 points to 5,158.

On the upside

Williams Cos. (NYSE: WMB) rejected a $48 billion buyout offer and announced that it was exploring strategic options to increase shareholder value.

Fitbit (NYSE: FIT) stock continued soaring.

Speculation that Greece may be close to deal lifted shares of National Bank of Greece (NYSE: NBG).
 
On the downside

Investors locked in profits on Magnum Hunter Resources (NYSE: MHR).

Sequential Brands (Nasdaq: SQBG) will acquire Martha Stewart Living (NYSE: MSO) in a cash and stock deal valued at approximately $353 million.

Shares of Ambarella (Nasdaq: AMBA) continued tumbling.
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 3 on the NYSE and by more than 2 to 1 on Nasdaq. The broader S&P 500 climbed 16 points to 2126. Bitcoin added $2 to $245.
Massive withdrawals from Greek banks raised concerns about the solvency of the nation. The markets closed sharply lower with the Dow tumbling 99 points to 18,015. Nasdaq lost 15 points to 5,117.

On the upside

Shares of Fogo de Chao (Nasdaq: FOGO) surged in its market debut.

TheStreet named Fortress Biotech (Nasdaq: FBIO) as one of five under-$10 biopharmaceutical stocks that was poised to soar.

Shares of Fitbit (NYSE: FIT) continued to surge.
 
On the downside

Shares of EXCO Resources (NYSE: XCO) continued falling.

Mindbody (Nasdaq: MB) stock plunged on its first trading day.

Tekmira Pharmaceuticals (Nasdaq: TKMR) ended enrollment in a Phase II clinical trial of its Ebola treatment TKM-Ebola-Guinea due to disappointing results.
 
In the broad market, declining issues outpaced advancers by a margin of more than 7 to 5 on the NYSE and by more than 5 to 4 on Nasdaq. The broader S&P 500 tumbled 11 points to 2109. Bitcoin slipped $3 to $244.
The markets opened lower with the Dow losing 28 points to 18,087 as the stalemate between Greece and Europe continued. Nasdaq slipped 13 points to 5,119.

On the upside

AirMedia (Nasdaq: AMCN) received an offer from chairman and chief executive Herman Man Guo to take the company private.

Jana Partners acquired a 7.2% stake in ConAgra Foods (NYSE: CAG).

Harvest Natural Resources (NYSE: HNR) raised $32.2 million through the sale of senior secured and convertible notes.
 
On the downside

Healthways (Nasdaq: HWAY) cut its full year revenue forecast.

Profit taking weighed down shares of SouFun Holdings (NYSE: SFUN).

Raymond James downgraded Finisar (Nasdaq: FNSR) from a Strong Buy rating to an Outperform rating.
 
In the broad market, declining issues outpaced advancers by a margin of more than 9 to 7 on both the NYSE and on Nasdaq. The broader S&P 500 lost 2 points to 2118. Bitcoin slipped $3 to $244.
A drop in first time applications for unemployment benefits to its lowest level in nearly 15 years sent the markets soaring to a sharply higher close with the Dow surging 180 points to 18,115. Nasdaq leaped 68 points to 5,132.

On the upside

The Wall Street Journal reported that Sequential Brands (Nasdaq: SQBG) was close to finalizing a deal to acquire Martha Stewart Living Omnimedia (NYSE: MSO).

Cantor Fitzgerald lifted its price target on Synergy Pharmaceuticals (Nasdaq: SGYP) from $8.50 to $14.00.

PBF Energy (NYSE: PBF) will pay approximately $322 million to acquire Chalmette Refining from ExxonMobil (NYSE: XOM) and PDV Chalmette.
 
On the downside

Profit taking continued to sink shares of Advaxis (Nasdaq: ADXS).

Agenus (Nasdaq: AGEN) will present at the 2015 JMP Securities Life Sciences Conference next Tuesday.

SuperCom (Nasdaq: SPCB) priced its public offering of 2.1 million common shares at the discounted price of $12 per share.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 2 to 1 on the NYSE and by nearly 5 to 2 on Nasdaq. The broader S&P 500 soared 20 points to 2121. Bitcoin held steady at $247.
The markets extended its gains during the midday with the Dow rocketing 204 points to 18,139 as first time applications for unemployment benefits tumbled. Nasdaq jumped 68 points to 5,133.

On the upside

Shares of Fitbit (NYSE: FIT) surged on its first trading day.

Univar (NYSE: UNVR) stock soared in its market debut.

Learning Tree International (Nasdaq: LTRE) launched its new Activity-Based Intelligence training curriculum and certifications.
 
On the downside

Bankrate (NYSE: RATE) reported higher first quarter earnings and revenue but the results fell short of expectations and the company forecast current quarter below estimates.

SunTrust cut its price target on Goodrich Petroleum (NYSE: GDP) from $7 to $4.

Jabil Circuit (NYSE: JBL) reported lower third quarter earnings and forecast current quarter revenue below expectations.
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 7 to 2 on the NYSE and by 3 to 1 on Nasdaq. The broader S&P 500 climbed 19 points to 2120. Bitcoin held steady at $247.
Jobless claims tumbled to a near 15-year low to send the markets soaring to a sharply higher open with the Dow leaping 166 points to 18,101. Nasdaq surged 52 points to 5,117.

On the upside

Radius Health (Nasdaq: RDUS) reported positive data from the first six month of ACTIVExtend and the 25 month combined data from ACTIVE and ACTIVExtend.

BioMarin Pharmaceutical (Nasdaq: BMRN) reported upbeat data from a Phase 2 study of BMN 111 to treat the most common form of human dwarfism.

Lumenis (Nasdaq: LMNS) will be acquired by XIO Group for a premium of approximately $510 million in cash.
 
On the downside

Oracle (NYSE: ORCL) disappointed with lower fourth quarter earnings and revenue that fell short of analyst expectations.

Noranda Aluminum (NYSE: NOR) suspended its quarterly dividend and retained the services of Morgan Stanley to evaluate strategic options.

Shares of AirMedia Group (Nasdaq: AMCN) continued falling.
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 3 to 1 on the NYSE and by nearly 5 to 2 on Nasdaq. The broader S&P 500 climbed 16 points to 2116. Bitcoin added $2 to $249.
The Federal Reserve maintained interest rates at historic lows and lowered its GDP forecast for 2015 sending the markets to a modestly higher close with the Dow gaining 31 points to 17,935. Nasdaq rose 9 points to 5,064.

On the upside

TripAdvisor (Nasdaq: TRIP) expanded its partnership with Marriott International (Nasdaq: MAR) to the global market.

Shares of Chinese companies E-Commerce China DangDang (Nasdaq: DANG), Jumei International (NYSE: JMEI) and SouFun Holdings (NYSE: SFU) all rose on Qihoo's (NYSE: QIHU) buyout offer.

TheStreet said yesterday that Applied Micro (Nasdaq: AMCC) could be acquired for a billion dollars.
 
On the downside

Retreating crude oil prices weighed down shares of EXCO Resources (NYSE: XCO).

Azure Midstream Partners (NYSE: AZUR) priced its public offering of 3.5 million common units at the discounted price of $14.17 per common unit.

Revenue from Newpark Resources' (NYSE: NR) Fluids Systems slipped.
 
In the broad market, advancing issues outpaced decliners by a margin of 10 to 9 on the NYSE while decliners edged out advancers by 10 to 9 on Nasdaq. The broader S&P 500 rose 4 points to 2100. Bitcoin added $2 to $248.
The markets traded modestly higher with the Dow rising 19 points to 17,923 as investors await the Federal Reserve's statement. Nasdaq added 4 points to 5,060.

On the upside

Noranda Aluminum Holding (NYSE: NOR) secured $15 million in financing to complete its state-of-the-art redraw rod mill.

Shares of Nivalis Therapeutics (Nasdaq: NVLS) soared on its first trading day.

Hill-Rom Holdings (NYSE: HRC) will acquire Welch Allyn for approximately $2.05 billion in cash and stock.
 
On the downside

Davids Tea (Nasdaq: DTEA) fell to a loss for the first quarter.

Investors locked in profits on Juno Therapeutics (Nasdaq: JUNO).

Profit taking weighed down shares of Align Technology (Nasdaq: ALGN).
 
In the broad market, advancing issues barely edged out decliners by a slim margin on the NYSE while advancers outpaced decliners by more than 10 to 9 on Nasdaq. The broader S&P 500 held steady at 2096. Bitcoin added $3 to $249.
Merger and acquisition activity lifted the markets to a higher open with the Dow rising 21 points to 17,925. Nasdaq gained 14 points to 5,070.

On the upside

Synergy Pharmaceuticals (Nasdaq: SGYP) reported positive results from a Phase 3 study of its chronic idiopathic constipation treatment plecanatide.

Allergan will pay a premium of approximately $2.1 billion in cash and stock to acquire Kythera Biopharmaceuticals (Nasdaq: KYTH).

A consortium of investors lead by Qihoo 360 Technology (NYSE: QIHU) chairman and chief executive Hongyi Zhou offered to a premium of $77 per American Depositary Share to take the company private.
 
On the downside

Ocata Therapeutics (Nasdaq: OCAT) priced its offering of 5.5 million common shares at the discounted price of $5.50 per share.

Shares of AirMedia Group (Nasdaq: AMCN) extended its losses.

Rock Creek Pharmaceuticals (Nasdaq: RCPI) announced a registered direct offering to raise approximately $3.7 million.
 
In the broad market, advancing issues outpaced decliners by a margin 2 to 1 on both the NYSE and on Nasdaq. The broader S&P 500 added 4 points to 2100. Bitcoin climbed $6 to $252.
The markets closed sharply higher with the Dow surging 113 points to 17,904 ahead of the Federal Reserve's monetary policy meeting tomorrow. Nasdaq climbed 25 points to 5,055.

On the upside

Alkermes (Nasdaq: ALKS) will present at the American Society of Clinical Psychopharmacology Annual Meeting next week.

Rising crude oil prices lifted shares of Petrobras (NYSE: PBR).

Adams Pharmaceuticals (Nasdaq: ADMS) reported additional upbeat findings from its Phase2/3 study of ADS-5102 to treat levodopa-induced dyskinesia.
 
On the downside

Profit taking weighed down shares of Advaxis (Nasdaq: ADXS).

Comverse (Nasdaq: CNSI) widened first quarter losses more than expected as revenue fell.

Robert W. Baird downgraded Methode Electronics (NYSE: MEI) from an Outperform rating to a Neutral rating.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE and by 7 to 5 on Nasdaq. The broader S&P 500 gained 11 points to 2096. Bitcoin climbed $9 to $245.
The markets extended its gains during the midday with the Dow soaring 112 points to 17,903 even as the Greek impasse continued. Nasdaq gained 28 points to 5,058.

On the upside

Nationwide Building Society selected NCR (NYSE: NCR) to provide personalized banking services. Also, Reuters reported that Blackstone Group (NYSE: BX) and Carlyle Group (Nasdaq: CG) offered to acquire NCR for $10 million.

CDK Global (Nasdaq: CDK) announced a transformation plan to enhance shareholder value.

Shares of Anthera Pharmaceuticals (Nasdaq: ANTH) continued rising.
 
On the downside

Tahoe Resources (NYSE: TAHO) announced a secondary offering of more than 58 million common shares.

Bellicum Pharmaceuticals (Nasdaq: BLCM) secured a non-exclusive worldwide license to certain proprietary cell lines from BioVec Pharma.

Stifel downgraded Greenbrier (NYSE: GBX) from a Buy rating to a Hold rating.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE and by nearly 3 to 2 on Nasdaq. The broader S&P 500 gained 11 points to 2095. Bitcoin rose $8 to $244.
A surge in building permits lifted the markets to a higher open with the Dow rising 31 points to 17,822. Nasdaq added a point to 5,031.

On the upside

The Food and Drug Administration has agreed to allow Aerie Pharmaceuticals (Nasdaq: AERI) to change the primary endpoint range of its second Phase 3 registration trial of Rhopressa.

Coty (NYSE: COTY) will acquire the beauty assets of Proctor & Gamble (NYSE: PG).

The European Patent Office granted a patent to Great Basin Scientific (Nasdaq: GBSN) for its on-chip amplification technology which is currently patented in the U.S.
 
On the downside

A small study of Avalanche Biotechnologies' (Nasdaq: AAVL) age-related chronic eye disease treatment AVA-101 achieved its safety goal but demonstrated only modest vision improvement.

Shares of National Bank of Greece (NYSE: NBG) continued falling.

Oshkosh (NYSE: OSK) blamed bad weather for cutting its full year profit forecast.
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 4 on the NYSE while advancers barely edged out decliners by a slim margin on Nasdaq. The broader S&P 500 rose 2 points to 2087. Bitcoin added $2 to $239.
Concerns about the stalemate between Greece and its creditors sent the markets down to a sharply lower close with the Dow tumbling 107 points to 17,791. Nasdaq fell 21 points to 5,029.

On the upside

Shares of Invuity (Nasdaq: IVTY) surged in its market debut.

Atara Biotherapeutics (Nasdaq: ATRA) exercised its exclusive option with Memorial Sloan Kettering Cancer Center to license certain clinical stage, allogeneic T-cell therapies.

Shares of Kythera Biopharmaceuticals (Nasdaq: KYTH) continued rising.
 
On the downside

Sangamo BioSciences (Nasdaq: SGMO) chief scientific officer Philip Gregory left the biopharmaceutical to join Bluebird Bio (Nasdaq: BLUE).

Investors locked in profits on Sage Therapeutics (Nasdaq: SAGE).

Profit taking weighed down shares of Caesars Acquisition (Nasdaq: CACQ).
 
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by more than 7 to 5 on Nasdaq. The broader S&P 500 lost 9 points to 2084. Bitcoin added $4 to $237.
The collapse of talks between Greece and its creditors sent the markets tumbling with the Dow plunging 130 points to 17,768. Nasdaq dropped 26 points to 5,024.

On the upside

RedHill Biopharma (Nasdaq: RDHL) reported positive results from a Phase III study of RHB-105 to treat H. pylori infection.

Shares of Anthera Pharmaceuticals (Nasdaq: ANTH) continued rising.

The Wall Street Journal reported that Anthem (NYSE: ANTM) offered to acquire Cigna (NYSE: CI).
 
On the downside

Canaccord Genuity analyst John Newman cut his price target on Agios Pharmaceuticals (Nasdaq: AGIO) from $103 to $93.

Profit taking weighed down shares of Leju Holdings (NYSE: LEJU).

Investors locked in profits on E-Commerce China Dangdang (NYSE: DANG).
 
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by nearly 7 to 5 on Nasdaq. The broader S&P 500 fell 10 points to 2083. Bitcoin added $3 to $236.
Talks between Greece and its credit collapsed over the weekend to send the markets tumbling to a sharply lower open with the Dow plummeting 162 points to 17,736. Nasdaq plunged 57 points to 4,993.

On the upside

Cox Automotive will acquire Dealertrack Technologies (Nasdaq: TRAK) in an all cash transaction valued at approximately $4 billion.

Niska Gas Storage Partners (NYSE: NKA) will be acquired by Brookfield Infrastructure for a premium of $4.225 per common unit in cash.

Standard Pacific (NYSE: SPF) will merge with Ryland Group (NYSE: RYL) to become the nation's fourth largest homebuilder.
 
On the downside

The collapse of talks between Greece and its creditors over the weekend weighed down shares of National Bank of Greece (NYSE: NBG).

AirMedia (Nasdaq: AMCN) will sell 75% of its equity interest in AM Advertising to Beijing Longde Wenchuang Fund Management.

iDreamSky Technology (Nasdaq: DSKY) chair and chief executive officer Michael Xiangyu Chen offered to take the company private for $14 per American Depositary Share.
 
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 1 on the NYSE and by more than 4 to 1 on Nasdaq. The broader S&P 500 dropped 19 points to 2074. Bitcoin added $2 to $235.
Stalled Greek debt negotiations sent the markets tumbling to a sharply lower close with the Dow plummeting 140 points to 17,898. Nasdaq tumbled 31 points to 5,051.

On the upside

China Sunergy (Nasdaq: CSUN) narrowed fourth quarter losses.

Shares of Origin Agritech (Nasdaq: SEED) continued rising.

Shares of NeoPhotonics (NYSE: NPTN) extended its gains from yesterday when Raymond James upgraded the company from a Market Perform rating to an Outperform rating.
 
On the downside

Falling crude oil prices weighed down shares of oilfield services provider Weatherford International  (NYSE: WFT).

Although Cloud Peak Energy (NYSE: CLD) met financial benchmarks to qualify for self-bonding, the stock price fell as rival coal producers faced the possibility of sharply higher insurance premiums.

Profit taking continued to sink shares of Galena Biopharm (Nasdaq: GALE).
 
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by 7 to 5 on Nasdaq. The broader S&P 500 dropped 14 points to 2094. Bitcoin added $1 to $230.
Uncertainty over Greek negotiations sent the markets tumbling during the midday with the Dow plunging 148 points to 17,890. Nasdaq dropped 28 points to 5,053.

On the upside

Shares of Wingstop (Nasdaq: WING) surged on its first trading day.

Sun Trust Robinson initiated coverage of Supernus Pharmaceuticals (Nasdaq: SUPN) with a Buy rating.

Amicus Therapeutics (Nasdaq: FOLD) raised $225 million through a common stock offering.
 
On the downside

Agios Pharmaceuticals (Nasdaq: AGIO) reported positive interim data from a Phase 1 study of AG-348 but the stock price fell.

Concerns that Peabody Energy (Nasdaq: BTU) may have to pay substantially more for environmental damage insurance sent the stock price down.

Esperion Therapeutics (Nasdaq: ESPR) extended its losses.
 
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by nearly 3 to 2 on Nasdaq. The broader S&P 500 dropped 14 points to 2094. Bitcoin added $1 to $230.
The markets opened lower with the Dow tumbling 109 points to 17,929 over strained Greek debt negotiations. Nasdaq dropped 22 points to 5,059.

On the upside

ITT Educational Services (NYSE: ESI) reported sharply higher first quarter earnings.

Sunesis Pharmaceuticals (Nasdaq: SNSS) reported additional upbeat data from the VALOR trial of vosaroxin and cytarabine to treat relapsed or refractory acute myeloid leukemia.

Shares of Sky-mobi (Nasdaq: MOBI) continued climbing.
 
On the downside

LeapFrog (NYSE: LF) widened fourth quarter losses more than expected as revenue fell.

The Food and Drug Administration suggested that AVEO (Nasdaq: AVEO) develop its biomarker assay before beginning a phase 3 study of tivozanib to treat low colorectal cancer.

Investors locked in profits on Axovant Sciences (NYSE: AXON).
 
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 2 on the NYSE and by nearly 2 to 1 on Nasdaq. The broader S&P 500 fell 11 points to 2097. Bitcoin added $1 to $231.
The markets closed higher with the Dow gaining 38 points to 18,039 as retail sales rose more than expected. Nasdaq rose 5 points to 5,082.

On the upside

Shares of Axovant Sciences (NYSE: AXON) surged on its first trading day.

Krispy Kreme Doughnuts (NYSE: KKD) reported higher first quarter earnings that topped analyst estimates.

Biotie Therapies (Nasdaq: BITI) stock surged in its market debut.
 
On the downside

A jury ruled against the plaintiff in a patent infringement case that Marathon Patent Group (Nasdaq: MARA) supported.

Shares of Peabody Energy (NYSE: BTU) extended its losses.

Noranda (NYSE: NOR) reached an interim agreement with the Government of Jamaica over production levies.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 2 on the NYSE while advancers barely edged out decliners by a slim margin on Nasdaq. The broader S&P 500 added 3 points to 2108. Bitcoin edged up a fraction to $230.
A stronger than expected 1.2% jump in retail sales lifted the markets to a higher open with the Dow climbing 78 points to 18,079. Nasdaq gained 21 points to 5,098.

On the upside

China Jo-Jo Drugstores (Nasdaq: CJJD) reported that annual online sales surged at least 90% while sales at its own online site leaped more than 200%.

Box (NYSE: BOX) reported a narrower than expected loss for the first quarter as revenue soared prompting the company to lift its full year outlook.

Roth Capital initiated coverage of PlasmaTech Biopharmaceuticals (Nasdaq: PTBI) with a Buy rating.
 
On the downside

Shares of MannKind (Nasdaq: MNKD) extended its losses.

Scorpio Bulkers (NYSE: SALT) stock continued falling.

Oppenheimer downgraded Chesapeake Energy (NYSE: CHK) from an Outperform rating to a Perform rating.
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 2 on the NYSE and by 7 to 5 on Nasdaq. The broader S&P 500 gained 7 points to 2112. Bitcoin edged up a fraction to $229.
Possible progress in Greek negotiations boosted the markets to a sharply higher close with the Dow leaping 236 points to 18,000. Nasdaq soared 62 points to 5,076.

On the upside

DS Healthcare Group (Nasdaq: DSKX) introduced its over-the-counter tablet Integra to thicken hair and improve hair health.

Sigma Designs (Nasdaq: SIGM) narrowed first quarter losses more than expected as revenue soared.

Bloomberg reported that Vale (NYSE: VALE) chief executive Murilo Ferreira expects Chinese iron ore demand to increase in the second half of 2015.
 
On the downside

MannKind (Nasdaq: MNKD) chief financial officer Matthew J. Pfeffer said that its inhaled insulin Afrezza is still not at the break even point.

Investors continued to lock in profits on Oculus Innovative Sciences (Nasdaq: OCLS).

Vimicro International (Nasdaq: VIMC) reported a loss for the first quarter.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on both the NYSE and on Nasdaq. The broader S&P 500 soared 25 to 2105. Bitcoin eased a fraction to $228.
A report that Germany may agree to the latest Greek proposal sent the market soaring with the Dow rocketing 263 points to 18,027. Nasdaq surged 72 points to 5,085.

On the upside

Bargain hunters snapped up shares of E-Commerce China Dangdang (NYSE: DANG).

Heron Therapeutics (Nasdaq: HRTX) priced its offering of 4.8 million common shares at $24.75 per share.

Shares of ChinaCache International Holdings (Nasdaq: CCIH) climbed again.
 
On the downside

Scorpio Bulkers (NYSE: SALT) extended its losses.

Profit taking weighed down shares of Sears Holdings (Nasdaq: SHLD).

Rock Creek Pharmaceuticals (Nasdaq: RCPI) president and director Christopher C. Chapman, M.D. resigned.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 1 on both the NYSE and on Nasdaq. The broader S&P 500 soared 27 to 2107. Bitcoin eased a fraction to $229.
Rising crude oil prices sent the markets soaring with the Dow surging 147 points to 17,911. Nasdaq gained 32 points to 5,046.

On the upside

Tokio Marine will pay a premium of approximately $7.5 billion to acquire HCC Insurance Holdings (NYSE: HCC).

Zhejiang Aokang Shoes acquired a strategic equity interest of approximately 25.66% in LightInTheBox (NYSE: LITB).

Recon Technology (Nasdaq: RCON) received Contractor Qualification from Jianghan Oilfield Construction Engineering Company, a subsidiary of China Petroleum & Chemical (NYSE: SNP).
 
On the downside

Boulder Brands (Nasdaq: BDBD) chief executive Steve Hughes resigned.

Shares of Esperion Therapeutics (Nasdaq: ADXS) plummeted over concerns that the Food and Drug Administration may reject the company's LDL cholesterol reducing drug ETC-1002 .

Francesca's Holdings (Nasdaq: FRAN) disappointed with lower first quarter earnings that fell short of expectations and forecast current quarter results below estimates.
 
In the broad market, declining issues outpaced advancers by a margin of nearly 3 to 1 on the NYSE while advancers edged out decliners by nearly 5 to 2 on Nasdaq. The broader S&P 500 climbed 14 to 2094. Bitcoin held steady at $230.

Flat close over rate concerns

|
The markets closed flat with the Dow slipping 2 points to 17,764 as upbeat economic data sparked concerns of a rate hike. Nasdaq lost 7 points to 5,013.

On the upside

Lululemon Athletica (Nasdaq: LULU) reported sharply higher first quarter earnings that beat analyst estimates as revenue rose.

Isle of Capri Casinos (Nasdaq: ISLE) reversed year ago losses to post a stronger than expected profit for the fourth quarter.

Shares of Vical (Nasdaq: VICL) soared in anticipation of the release of Phase 1/2 clinical trial results of its Vaxfectin-formulated therapeutic vaccine to treat herpes simplex virus type 2.
 
On the downside

The Food and Drug Administration granted 510(k) clearance to Oculus Innovative Sciences (Nasdaq: OCLS) for its Alevicyn SG Antipruritic Spray Gel but the stock price fell as investors locked in profits.

Profit taking weighed down shares of Advaxis (Nasdaq: ADXS).

Scorpio Bulkers (NYSE: SALT) will offer up to $200 million worth of common stock.
 
In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 3 on the NYSE and by more than 3 to 2 on Nasdaq. The broader S&P 500 edged up a fraction to 2080. Bitcoin added $1 to $230.
The markets traded mixed during the midday with the Dow rising 15 points to 17,782 as April job openings soared to a 15-year high. Nasdaq lost 14 points to 5,007.

On the upside

MaxLinear (NYSE: MXL) lifted its second quarter revenue outlook.

Sage Therapeutics (Nasdaq: SAGE) reported positive results from an exploratory clinical trial of SAGE-547 to treat postpartum depression.

Alliance One International (NYSE: AOI) swung to a profit for the fourth quarter.
 
On the downside

bebe stores (Nasdaq: BEBE) owner and chairman Manny Mashouf will sell nearly 46.9 million shares of company stock.

Christopher & Banks (NYSE: CBK) fell to a loss for the first quarter as revenue dropped and the company forecast second quarter as well as full year revenue below expectations.

Ironwood Pharmaceuticals (Nasdaq: IRWD) will offer $300 million in convertible senior notes.
 
In the broad market, declining issues outpaced advancers by a margin of 5 to 4 on the NYSE and by more than 9 to 7 on Nasdaq. The broader S&P 500 added 2 points to 2081. Bitcoin rose $1 to $230.
Wholesale inventories rose in April but the markets opened lower with the Dow falling 44 points to 17,721 after European Union officials declared that a new reform proposal submitted by Greece was insufficient. Nasdaq dropped 33 points to 4,988.

On the upside

LightPath Technologies (Nasdaq: LPTH) will supply firefighting thermal imaging cameras with its Infrared 40 degree Field of View molded optical lens assembly.

Newmont Mining (NYSE: NEM) will pay approximately $820 million in cash to acquire AngloGold Ashanti's (NYSE: AU) Cripple Creek & Victor gold mine.

Tsinghua Unigroup will pay approximately $123.8 million in cash for approximately 63.5 million shares of 500.com (NYSE: WBAI).
 
On the downside

Quiksilver (NYSE: ZQK) reported a wider than expected loss for the second quarter prompting the company to withdraw its full year guidance.

Burlington Stores (NYSE: BURL) reported higher first quarter earnings and revenue but revenue fell short of expectations.

Hovnanian Enterprises (NYSE: HOV) widened second quarter losses more than expected.
 
In the broad market, declining issues outpaced advancers by a margin of more than 7 to 5 on the NYSE and by nearly 5 to 2 on Nasdaq. The broader S&P 500 slipped 3 points to 2075. Bitcoin added $2 to $230.
The markets closed sharply lower with the Dow falling 82 points to 17,766 as the deadlock between Greece and its creditors continued. Nasdaq dropped 46 points to 5,021.

On the upside

24/7 Wall St. noted that at last week's American Society of Clinical Oncology annual meeting, Immunomedics (Nasdaq: IMMU) reported positive mid-stage results from a clinical study of sacituzumab govitecan in treating breast cancer.

Zacks Equity Research suggested that E-House (China) Holdings (NYSE: EJ) would be a good investment.

Shares of ECPM Holdings (NYSE: GI) climbed in its market debut.
 
On the downside

Raymond James downgraded Delta Air Lines (NYSE: DAL) from a Strong Buy rating to an Outperform rating.

Profit taking weighed down shares of 500.com (NYSE: WBAI).

Pacific Crest Securities upgraded LendingClub (NYSE: LC) from a Sector Weight rating to an Overweight rating but the stock price fell.
 
In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 2 on the NYSE and by more than 5 to 3 on Nasdaq. The broader S&P 500 dropped 13 points to 2079. Bitcoin rose $5 to $229.
Concerns that Greece may not reach an agreement with its creditors sent the markets down during the midday with the Dow tumbling 73 points to 17,775. Nasdaq plunged 50 points to 5,017.

On the upside

Ballard Power Systems (Nasdaq: BLDP) signed license and supply agreements valued at approximately $10 million to provide fuel cell Power Products and Technology Solutions for 33 clean energy buses in China.

PetroQuest Energy (NYSE: PQ) completed the sale of its Woodford Shale and Mississipian Lime assets to WSGP Gas Producing.

Pozen (Nasdaq: POZN) will acquire Tribute Pharmaceuticals in a deal valued at approximately $146 million. After completing the acquisition, Pozen will relocate its headquarters to Ireland.
 
On the downside

The New York Stock Exchange issued a public reprimand letter to ITT Educational Services (NYSE: ESI) for failing to comply with listing rules.

Profit taking weighed down shares of Pixelworks (Nasdaq: PXLW).

Shares of JetBlue (Nasdaq: JBLU) fell over concerns that increasing airline capacity would negatively impact earnings.
 
In the broad market, declining issues outpaced advancers by a margin of more than 2 to 1 on the NYSE and by more than 5 to 3 on Nasdaq. The broader S&P 500 dropped 12 points to 2080. Bitcoin added $3 to $227.
The markets opened lower with the Dow losing 28 points to 17,821 as negotiations between Greece and its creditors remain deadlocked. Nasdaq fell 15 points to 5,053.

On the upside

Shares of MannKind (Nasdaq: MNKD) continued rising.

Synthesis Energy (Nasdaq: SYMX) announced the commissioning phase of an industrial syngas gasification plant in China.

PlasmaTech Biopharmaceuticals (Nasdaq: PTBI) has licensed an AAV gene therapy to treat juvenile Batten disease from UNeMed.
 
On the downside

Investors locked in profits on Wynn Resorts (Nasdaq: WYNN).

Profit taking weighed down shares of Yingli Green Energy (NYSE: YGE).

Raymond James downgraded American Airlines (NYSE: AAL) from an Outperform rating to a Market Perform rating.
 
In the broad market, declining issues outpaced advancers by a margin of more than 7 to 5 on both the NYSE and on Nasdaq. The broader S&P 500 slipped 3 points to 2089. Bitcoin added $3 to $227.
The markets closed mixed with the Dow dropping 56 points to 17,849 as concerns over a possible increase in interest rates tempered enthusiasm for a strong jobs report. Nasdaq rose 9 points to 5,068.

On the upside

Shares of Qihoo 360 (NYSE: QIHU) continued climbing.

Moffitt Cancer Center treated its first non-Hodgkin's lymphoma patient in Kite Pharma's (Nasdaq: KITE) Phase 1/2 clinical trial of KTE-C19.

Shares of ECPM Holdings (NYSE: GI) soared in its market debut.
 
On the downside

New Media Investment Group (NYSE: NEWM) extended its losses.

Shares of Sears Holdings (Nasdaq: SHLD) fell ahead of its earnings release next Monday.

Third quarter earnings rose for Thor Industries (NYSE: THO) but the results fell short of analyst expectations.
 
In the broad market, declining issues outpaced advancers by a margin of more than 10 to 9 on the NYSE while advancers edged out decliners by more than 5 to 3 on Nasdaq. The broader S&P 500 slipped 3 points to 2092. Bitcoin added a point to $225.
The markets turned negative during the midday with the Dow falling 41 points to 17,863 as an upbeat jobs report fueled concerns of a rate hike. Nasdaq held steady at 5,059.

On the upside

Shares of David's Tea (Nasdaq: DTEA) surged on its first trading day.

Evolent Health (NYSE: EVH) stock soared in its market debut.

Anthera Pharmaceuticals (Nasdaq: ANTH) announced additional upbeat data for its Phase 2b PEARL-SC study of blisibimod.
 
On the downside

Esterline Technologies (NYSE: ESL) disappointed with sharply lower second quarter earnings that fell far short of analyst expectations prompting the company to cut its full year outlook.

Shares of Caesars Entertainment (Nasdaq: CZR) continued falling.

Lands' End (Nasdaq: LE) reported sharply lower first quarter earnings and revenue.
 
In the broad market, declining issues outpaced advancers by a margin of 7 to 5 on the NYSE while advancer edged out decliners by 10 to 9 on Nasdaq. The broader S&P 500 slipped 2 points to 2093. Bitcoin added a point to $225.
The markets opened higher with the Dow rising 13 points to 17,918 as the nation's employers added more jobs than expected last month. Nasdaq added 6 points to 5,065.

On the upside

JA Solar Holdings (Nasdaq: JASO) chief executive Baofang Jin offered to take the company private for a premium of $9.69 per American Depositary Share.

Yingli Green Energy (NYSE: YGE) widened losses for the first quarter but revenue rose to top estimates.

InterCloud Systems (Nasdaq: ICLD) received contracts from new clients totaling more than $1.5 million.
 
On the downside

Zumiez (Nasdaq: ZUMZ) reported higher first quarter earnings and revenue but company forecast second quarter results well below analyst expectations prompting downgrades.

First quarter earnings and revenue rose for Vince Holding (NYSE: VNCE) but the company lowered its full year earnings and revenue outlook.

Investors locked in profits on Lightbridge (Nasdaq: LTBR).
 
In the broad market, declining issues outpaced advancers by a margin of 5 to 3 on the NYSE and by nearly 5 to 4 on Nasdaq. The broader S&P 500 rose 2 points to 2098. Bitcoin added a point to $225.
The markets tumbled to a sharply lower close with the Dow plunging 170 points to 17,905 on news that Greece would miss its debt payment tomorrow. Nasdaq dropped 40 points to 5,059.

On the upside

The Korean Intellectual Property Office granted Lightbridge (Nasdaq: LTBR) a patent covering the Company's multi-lobed metallic fuel rod design and fuel assemblies.

Shares of Oculus Innovative Sciences (Nasdaq: OCLS) surged ahead of its earnings release next week.

Mindray Medical (NYSE: MR) received an offer to take the company private for a premium of $30 per American Depositary Share.
 
On the downside

National Bank of Greece (NYSE: NBG) stock fell on news that Greece will not be able to make its debt payment to the International Monetary Fund tomorrow.

Caesars Entertainment (Nasdaq: CZR) entered long term agreements with Sun Country and Via Airlines.

TheStreet recommended that investors sell Biolife Solutions (Nasdaq: BLFS).
 
In the broad market, declining issues outpaced advancers by a margin of nearly 7 to 2 on the NYSE and by more than 5 to 2 on Nasdaq. The broader S&P 500 tumbled 18 points to 2095. Bitcoin slipped a point to $224.
Falling crude oil prices sent the markets tumbling during the midday with the Dow plummeting 132 points to 17,953. Nasdaq fell 24 points to 5,074.

On the upside

Shares of DS Healthcare Group (Nasdaq: DSKX) continued rising after announcing a rewards program on Monday.

Gevo (Nasdaq: GEVO) has developed a process to produce jet fuel from wood waste.

VisionChina Media (Nasdaq: VISN) entered a financing transaction with Baidu (Nasdaq: BIDU) to jointly develop and monetize mobile app distribution and other mobile passenger services.
 
On the downside

Navistar International (NYSE: NAV) narrowed second quarter losses but revenue slipped to fall short of expectations.

Oxford Lane Capital (Nasdaq: OXLC) priced its public offering of 1.8 million common shares at the discounted price of $15.65 per share.

Prima BioMed (Nasdaq: PBMD) has regained Nasdaq listing compliance but the stock price slipped.
 
In the broad market, declining issues outpaced advancers by a margin of more than 3 to 1 on the NYSE and by 2 to 1 on Nasdaq. The broader S&P 500 dropped 12 points to 2101. Bitcoin edged up a fraction to $227.
The markets opened lower with the Dow losing 19 points to 18,056 as crude oil prices retreated. Nasdaq slipped 5 points to 5,094.

On the upside

AVEO Oncology (Nasdaq: AVEO) received written support from the Rapporteur and co-Rapporteur for the filing of a Marketing Authorization Application for tivozanib in Europe.

Opko Health (NYSE: OPK) will acquire Bio-Reference Laboratories (Nasdaq: BRLI) in an all stock deal valued at approximately $1.5 billion.

Five Below (Nasdaq: FIVE) reported higher first quarter earnings and revenue that beat analyst expectations.
 
On the downside

Investors locked in profits on Voltari (Nasdaq: VLTC).

China Finance Online (Nasdaq: JRJC) extended it losses.

VWR (Nasdaq: VWR) priced its public offering of 16 million common shares at the discounted price of $26.25 per share.
 
In the broad market, declining issues outpaced advancers by a margin of nearly 7 to 2 on both the NYSE and on Nasdaq. The broader S&P 500 slipped a point to 2112. Bitcoin held steady at $226. 
A narrowing of the nation's trade deficit boosted the markets to a higher close with the Dow gaining 64 points to 18,076. Nasdaq climbed 22 points to 5,099.

On the upside

Revance Therapeutics (Nasdaq: RVNC) will initiate a Phase 3 clinical trial of RT001 to treat crows feet lines and a Phase 2 study to treat hyperhidrosis.

Shares of Voltari (Nasdaq: VLTC) surged on no news.

Celator Pharmaceuticals (Nasdaq: CPXX) completed enrollment in a Phase 2 study of CPX-351 Liposome Injection in patients with acute hematologic malignancies.
 
On the downside

Peabody Energy (NYSE: BTU) will cut metallurgical coal production by 1.5 million tons per year at its North Goonyella Mine in Queensland, Australia.

Shares of Hanwha Q CELLS (Nasdaq: HQCL) extended its losses.

Ameren will not extend a power contract to Noranda Aluminum's (NYSE: NOR) smelter in New Madrid.
 
In the broad market, declining issues barely edged out advancers by a slim margin on the NYSE while advancers outpaced decliners by more than 2 to 1 on Nasdaq. The broader S&P 500 added 4 points to 2114. Bitcoin held steady at $226.
Optimism that Greece will finalize an agreement with its creditors lifted the markets during the midday with the Dow climbing 68 points to 18,080. Nasdaq gained 18 points to 5,094.

On the upside

LightPath Technologies (Nasdaq: LPTH) launched its proprietary infrared product technologies.

Shares of Pixelworks (Nasdaq: PXLW) rose again after announcing on Monday that the company's True Clarity display enhancements will be used in the ASUS Hero ZenPad tablet.

NQ Mobile (NYSE: NQ) stock continued climbing over the appointment on Monday of Roland Wu to the position of chief financial officer.
 
On the downside

Ocean Rig (Nasdaq: ORIG) priced its offering of approximately 28.5 million common shares at the discounted price of $7.00 per share.

Pomerantz Law Firm initiated an investigation into China Finance Online (Nasdaq: JRJC).

Violin Memory (NYSE: VMEM) reported a greater than expected loss for the first quarter as revenue fell.
 
In the broad market, declining issues barely edged out advancers by a slim margin on the NYSE while advancers outpaced decliners by more than 2 to 1 on Nasdaq. The broader S&P 500 rose 4 points to 2113. Bitcoin held steady at $226.
The markets surged to open sharply higher with the Dow soaring 140 points to 18,152 as the nation's trade deficit narrowed. Nasdaq climbed 32 points to 5,109.

On the upside

BioLife Solutions (Nasdaq: BLFS) reported new groups using the company's bioprevservation media products.

The Wall Street Journal reported that Synchronoss Technologies (Nasdaq: SNCR) was exploring a possible sale of the company for up to $2 billion.

Tang Capital Management's Kevin Tang bought 150,000 shares of Heron Therapeutics (Nasdaq: HRTX).
 
On the downside

Clean Diesel Technologies (Nasdaq: CDTI) announced a public offering of approximately 2.5 million common units at the discounted price of $2.05 per unit.

Vera Bradley (Nasdaq: VRA) fell to a greater than expected loss for the first quarter as revenue slipped and the company forecast current quarter results below estimates.

FCStone Merchant Services will originate and supply Gevo (Nasdaq: GEVO) with corn for a plant in Luverne.
 
In the broad market, declining issues outpaced advancers by a margin of more than 9 to 7 on the NYSE while advancers edged out decliners by 9 to 7 on Nasdaq. The broader S&P 500 lost 9 points to 2118. Bitcoin held steady at $227.
Despite strong auto sales, the markets closed lower with the Dow losing 28 points to 18,011 over concerns that Greece may not be able to make its first debt payment at the end of the week. Nasdaq slipped 6 points to 5,076.

On the upside

Wi-Lan (Nasdaq: WILN) acquired a portfolio of over 7,000 patents from Qimonda and will license the patents to Samsung.

Bargain hunters lifted shares of Peabody Energy (NYSE: BTU).

Rising crude oil prices lifted shares of Petrobas (NYSE: PBR).
 
On the downside

Shares of Vascular Biogenics (Nasdaq: VBLT) continued falling.

Investors locked in profits on ITT Educational Services (NYSE: ESI).

Bank of America Merrill Lynch and Goldman Sachs initiated coverage of Bojangles (Nasdaq: BOJA) with a Neutral rating while Barclays initiated coverage with an Equal Weight rating.
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 4 on the NYSE and by 7 to 5 on Nasdaq. The broader S&P 500 slipped 2 points to 2109. Bitcoin rose $4 to $227.

Strong auto sales lift markets

|
Strong auto sales lifted the markets during the midday with the Dow rising 32 points to 18,067. Nasdaq gained 11 points to 5,094.

On the upside

Zions Bancorp (Nasdaq: ZION) will restructure in order to improve profitability metrics prompting upgrades.

Halcon Resources (NYSE: HK) chief executive Floyd Wilson purchased one million shares of company stock.

Bloomberg reported that AstraZeneca (NYSE: AZN) would consider acquiring a pharmaceutical company similar to Juno Therapeutics (Nasdaq: JUNO).
 
On the downside

Shares of Puma Biotechnology (NYSE: PBYI) continued falling.

Regulus Therapeutics (Nasdaq: RGLS) president and chief executive Kleanthis G. Xanthopoulos has resigned.

Jeffries downgraded Iron Mountain (NYSE: IRM) from a Hold rating to an Underperform rating and cut its price target from $33 to $29.
 
In the broad market, advancing issues outpaced decliners by a margin of 3 to 2 on the NYSE and by nearly 7 to 3 on Nasdaq. The broader S&P 500 added 3 points to 2115. Bitcoin rose $2 to $225.
The markets opened lower with the Dow falling 47 points to 17,992 as Greece's first debt payment comes due on Friday. Nasdaq lost 12 points to 5,070.

On the upside

Clean Diesel Technologies (Nasdaq: CDTI) reported encouraging initial results for its Spinel(TM) proprietary clean emissions exhaust technology.

24/7 Wall Street listed Aveo Pharmaceuticals (Nasdaq: AVEO) as one of four overlooked winners of the American Society of Clinical Oncology's annual meeting.

Youku Tudou (NYSE: YOKU) partnered with Disney (NYSE: DIS) to exclusively market online in China the Marvel collection of movies and TV series.
 
On the downside

Stifel Nicolaus analyt George Askew downgraded Ctrip.com (Nasdaq: CTRP) from a Buy rating to a Hold rating.

Shares of Talen Energy (NYSE: TLN) fell after being spun off from PPL (NYSE: PPL) yesterday.

Investors locked in profits on ImmunoGen (Nasdaq: IMGN).
 
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on the NYSE and by more than 3 to 2 on Nasdaq. The broader S&P 500 fell 8 points to 2103. Bitcoin added $3 to $226.
The markets closed modestly higher with the Dow gaining 29 points to 18,040 as stalled consumer spending tempered enthusiasm for a strong jump in construction spending. Nasdaq rose 12 points to 5,082.

On the upside

Ignyta (Nasdaq: RXDX) reported positive interim results from two Phase 1 clinical trials of entrectinib.

Shares of Heron Therapeutics (Nasdaq: HRTX) continued soaring.

Affiliates of Apollo Global Management will acquire OM Group (NYSE: OMG) for a premium of $34 per share in cash.
 
On the downside

A researcher questioned the benefits of Puma Biotechnology's (NYSE: PBYI) neratinib in treating breast cancer given the side effects.

Goldman Sachs downgraded Cloud Peak Energy (NYSE: CLD) from a Neutral rating to a Sell rating.

Shares of Aeropostale (NYSE: ARO) continued falling.
 
In the broad market, advancing issues outpaced decliners by a margin of more than 10 to 9 on the NYSE while decliners barely edged out advancers by a slime margin on Nasdaq. The broader S&P 500 added 4 points to 2111. Bitcoin lost $7 to $223.
The markets advanced during the midday with the Dow climbing 74 points to 18,085 as the nation's construction spending soared 2.2% in April. Nasdaq gained 24 points to 5,094.

On the upside

Intel (Nasdaq: INTC) will pay a premium of approximately $16.7 billion to purchase Altera (Nasdaq: ALTR).

SINA (Nasdaq: SINA) chief executive Charles Chao will purchase $456 million worth of company stock in cash.

Shares of ITT Educational Services (NYSE: ESI) continued soaring.
 
On the downside

Shares of Caesars Entertainment (Nasdaq: CZR) extended its losses.

Investors continued to lock in profits on Prima Biomed (Nasdaq: PBMD).

Hanwha Q CELLS (Nasdaq: HQCL) will change the ratio of American Depositary Shares (ADS) to ordinary shares from one ADS representing five ordinary shares to one ADS representing 50 ordinary shares.
 
In the broad market, advancing issues outpaced decliners by a margin of nearly 5 to 3 on the NYSE and by more than 7 to 5 on Nasdaq. The broader S&P 500 gained 9 points to 2116. Bitcoin lost $6 to $224.
Construction spending rose at the quickest pace in six years but the markets opened lower with the Dow slipping 5 points to 18,005. Nasdaq lost 16 points to 5,053.

On the upside

ImmunoGen (Nasdaq: IMGN) reported upbeat from an ongoing Phase 1 trial of FRa-targeting antibody conjugate mirvetuximab soravtansine.

CTI BioPharma (Nasdaq: CTIC) reported positive data from a Phase 3 registration-directed trial of pacritinib to treat myelofibrosis.

Oncothyreon (Nasdaq: ONTY) presented positive data from several ongoing trials of ONT-380 in treating breast cancer.
 
On the downside

Shares of Transgenomic (Nasdaq: TBIO) continued falling.

Brean Capital downgraded Mirati Therapeutics (Nasdaq: MRTX) to a Hold rating from a Buy rating.

BioDelivery Sciences (Nasdaq: BDSI) increased its debt financing from MidCap Financial to $30 million.
 
In the broad market, advancing issues barely edged out decliners by a slim margin on the NYSE and by nearly 5 to 4 on Nasdaq. The broader S&P 500 lost 3 points to 2103. Bitcoin slipped $2 to $228.

About this Archive

This page is an archive of entries from June 2015 listed from newest to oldest.

May 2015 is the previous archive.

July 2015 is the next archive.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12